High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis

Table 2

Baseline and tumour characteristics of 110 patients with localized prostate cancer who were treated by a single session of high intensity focused ultrasound.

Mean age, years [range]	76.1 ± 6.2 [61–86]
Mean preoperative PSA, ng/mL [range]	12.1 ± 4.1 [0.55–49.0]
Mean prostate volume, mL [range]	29.3 ± 6.0 [18–39]
Hormone, (%)
Yes	37 (33.6)
No	73 (66.4)
Gleason score, (%)
≤6	69 (62.7)
7	24 (21.8)
≥8	17 (15.5)
Stage, (%)
T1	51 (46.4)
T2	59 (53.6)
D’Amico risk group, (%)
Low	40 (36.4)
Intermediate	49 (44.5)
High	21 (19.1)

Risk group based on D’Amico definition (according to Stage, Gleason, and PSA).